I agree he has comprehensive optics on the blood-b
Post# of 148179
I'm referring to Primary Outcome Measures : "Clinical Improvement as assessed by change in total symptom score (for fever, myalgia, dyspnea and cough)"
https://clinicaltrials.gov/ct2/show/NCT04343651
That is something he cannot know.
Do we know how all of the various trial outcomes are "weighted" by the FDA in terms of their decision making process?